• Latest Posts

FDA approves type 2 diabetes drug for children 10 and older

RetinAI and Boehringer Ingelheim to use AI to develop treatment for geographic atrophy

5 advancements in kidney disease research over the past year

Boehringer Ingelheim and 3T Biosciences to develop next-generation cancer immunotherapies

Psoriasis pustules disappear in over half of patients using Boehringer Ingelheim drug

In Depth 22 Nov 2021

How Will We Be Treating Cystic Fibrosis 10 Years From Now?

ADC Approval Buoys Spirits in Cancer Treatment Space

Boehringer Ingelheim Acquires Cancer Vaccine Biotech in €325M Deal

More News! 13 Sep 2018

Boehringer Ingelheim Acquires Oncolytic Virus Biotech Company

Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech

No Nonsense Boehringer Ingelheim Jettisons Failing Alzheimer’s Disease Drug